ZOSTAVAX™ Administered Concomitantly With PNEUMOVAX™ 23 (V211-012)(COMPLETED)

NCT00535730 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

473

Enrollment

INDUSTRY

Sponsor class

Conditions

Herpes Zoster
Pneumococcal Infection

Interventions

BIOLOGICAL: Zoster Vaccine, Live, (Oka-Merck), ZOSTAVAX™
BIOLOGICAL: Comparator: placebo (concomitant-vaccine matched)
BIOLOGICAL: Pneumococcal Vaccine, Polyvalent (23-valent), PNEUMOVAX™ 23

Sponsor

Merck Sharp & Dohme LLC